Form 4: INSMED CEO William Lewis Reports Stock Option Exercise and Sales Under 10b5-1 Plan

INSMED Inc.'s Chair and CEO, William Lewis, reported the exercise of stock options and subsequent sales of common stock through a pre-arranged 10b5-1 trading plan.

Summary

• William Lewis, Chair and CEO of INSMED Inc., reported transactions involving the company's common stock.
• On July 1, 2025, 6,830 shares of common stock were acquired by the Katie Procter Dynasty Trust through the exercise of stock options at an exercise price of $10.85 per share.
• Concurrently, the Katie Procter Dynasty Trust sold a total of 6,830 shares of common stock in three separate transactions: 3,666 shares at a weighted average price of $97.73, 2,349 shares at a weighted average price of $98.83, and 815 shares at a weighted average price of $99.61.
• All reported transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on September 12, 2024.
• Following these transactions, the Katie Procter Dynasty Trust beneficially owns 233,924 shares of common stock and 20,525 stock options.
• William Lewis directly owns 303,911 shares, which includes 357 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
• The William Lewis Family Legacy Trust beneficially owns 50,500 shares.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive due to the executive monetizing equity at favorable prices and the transparency provided by the 10b5-1 plan, indicating planned rather than opportunistic selling. However, it's largely neutral as it's a routine insider transaction.

Positives

• The exercise of stock options at a low price ($10.85) indicates a significant unrealized gain for the executive.
• The sales were conducted at high prices, ranging from $97.73 to $99.61, demonstrating the executive's ability to monetize vested equity at favorable market rates.
• The transactions were executed under a pre-arranged 10b5-1 trading plan, which indicates a planned and transparent approach to insider trading, reducing concerns about opportunistic selling.

Negatives

• The sale of 6,830 shares by a key executive, even if pre-planned, represents a reduction in their beneficial ownership through the Katie Procter Dynasty Trust.

Future Outlook

NA

Industry Context

This is a routine insider transaction filing and does not provide broader industry context.

Related Party Transactions

• The transactions involved shares beneficially owned by the Katie Procter Dynasty Trust and the William Lewis Family Legacy Trust, which are related parties to the reporting person, William Lewis.

Stakeholder Impact

• Shareholders: The sale of shares by a key executive, even if pre-planned, could be perceived as a slight negative, but the overall impact is likely minimal given the routine nature of 10b5-1 plan transactions and the relatively small percentage of total shares outstanding. The transparency of the 10b5-1 plan helps mitigate negative perceptions.

Key Dates

Keywords

INSMED Inc., INSM, SEC Form 4, Insider Trading, Stock Option Exercise, Stock Sale, William Lewis, 10b5-1 Plan, Executive Compensation, Equity Transactions